Loading
Life sciences · Interventional Study
ClinicalTrials.gov · September 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07792148). This is a study registration, not published results. Lead sponsor: Wake Forest University Health Sciences. Recruitment status: NOT_YET_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 80 participants (ESTIMATED). Conditions: PrEP Use. Interventions: BEHAVIORAL: PrEPared Minds/ Mentes PrEParadas - Cognitive Behavioral Therapy; OTHER: No Intervention. Primary outcome measures: Depression Questionnaire- PHQ-9 , Baseline; Depression - PHQ-9 instrument , Month 3 Post Randomization; Depression - PHQ-9 instrument , Month 6 Post Randomization; Anxiety Questionnaire - GAD-7 , Baseline; Anxiety - GAD-7 instrument , Month 3 Post Randomization; Anxiety - GAD-7 instrument , Month 6 Post Randomization; PrEP Uptake , Baseline; PrEP Uptake , Month 3 Post Randomization; PrEP Uptake , Month 6 Post Randomization. Brief summary: The purpose of this research study is to adapt, implement, and evaluate a 10-session mental health intervention with men who have sex with men at the Regional AIDS Interfaith Network to find out if it will reduce anxiety and depression and increase awareness and use of pre-exposure prophylaxis (PrEP), a medication to prevent HIV.